Philipps University Marburg
Clinical trials sponsored by Philipps University Marburg, explained in plain language.
-
New drug hopes to ease rare Heart-Lung condition
Disease control Not yet recruitingThis study tests a drug called sotatercept in 40 adults with congenital heart disease and Eisenmenger syndrome, a serious condition where blood flow in the lungs is blocked. The drug is given as a shot every three weeks for 24 weeks. The goal is to see if it safely lowers pressur…
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Triple threat: new combo therapy aims to tackle rare lung disease
Disease control Not yet recruitingThis phase 2 trial tests whether a triple combination of three drugs—sotatercept, an endothelin receptor antagonist, and a phosphodiesterase-5 inhibitor—can improve blood flow in the lungs of people newly diagnosed with pulmonary arterial hypertension (PAH). The study will enroll…
Phase: PHASE2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC